S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MRKR Marker Therapeutics Inc

2.11

-0.21 (-9.05%)

25 Jan 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Marker Therapeutics Charts.

Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Marker Therapeutics Charts.

Marker Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 21 January 2025 (6 days ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Saturday 18 January 2025 (1 week ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Tuesday 14 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Saturday 11 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 20 December 2024 (1 month ago) • Edgar (US Regulatory)

Marker Therapeutics Announces $16.1 Million Private Placement
Friday 20 December 2024 (1 month ago) • GlobeNewswire Inc.

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
Friday 20 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 17 December 2024 (1 month ago) • Edgar (US Regulatory)

More Marker Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions